Latest News
FDA approves Genentech's Enspryng as first at-home subcutaneous treatment for thyroid eye disease
16 October 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Friday that it has received US Food and Drug Administration (FDA) approval for Enspryng (satralizumab-mwge) to treat adults wit...
IBA and Framatome establish joint venture to scale up Astatine-211 production
16 October 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Friday that together with French nuclear energy company Framatome it has established Ekalia, a joint venture focused on b...
Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma
16 October 2026 - Expression Therapeutics Inc, a clinical-stage gene and cell therapy company, announced on Thursday that it has been awarded a National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Phase II grant of USD2,058,885 t...
Medtronic confirms separation of MiniMed
16 October 2026 - Healthcare technology company Medtronic plc (NYSE:MDT) announced on Thursday that it has completed its separation of MiniMed Group Inc (Nasdaq:MMED).Medtronic elected to exchange all of its remaining interest in MiniMed (a total of ...
SenderraRx receives reaccreditation in Specialty Pharmacy from ACHC
16 October 2026 - SenderraRx, an independent specialty pharmacy, announced on Thursday that it has earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC), including a Distinction in Oncology.The Oncology...